Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
Boguszewski MCS, Boguszewski CL, Chemaitilly W, Cohen LE, Gebauer J, Higham C, Hoffman AR, Polak M, Yuen KCJ, Alos N, Antal Z, Bidlingmaier M, Biller BMK, Brabant G, Choong CSY, Cianfarani S, Clayton PE, Coutant R, Cardoso-Demartini AA, Fernandez A, Grimberg A, Guðmundsson K, Guevara-Aguirre J, Ho KKY, Horikawa R, Isidori AM, Jørgensen JOL, Kamenicky P, Karavitaki N, Kopchick JJ, Lodish M, Luo X, McCormack AI, Meacham L, Melmed S, Mostoufi Moab S, Müller HL, Neggers SJCMM, Aguiar Oliveira MH, Ozono K, Pennisi PA, Popovic V, Radovick S, Savendahl L, Touraine P, van Santen HM, Johannsson G. Boguszewski MCS, et al. Among authors: guevara aguirre j. Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52. doi: 10.1530/EJE-21-1186. Eur J Endocrinol. 2022. PMID: 35319491 Free PMC article. Review.
Growth hormone modulates Trypanosoma cruzi infection in vitro.
Mora-Criollo P, Basu R, Qian Y, Costales JA, Guevara-Aguirre J, Grijalva MJ, Kopchick JJ. Mora-Criollo P, et al. Among authors: guevara aguirre j. Growth Horm IGF Res. 2022 Jun;64:101460. doi: 10.1016/j.ghir.2022.101460. Epub 2022 Apr 15. Growth Horm IGF Res. 2022. PMID: 35490602
The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
Gargosky SE, Wilson KF, Fielder PJ, Vaccarello MA, Guevara-Aguirre J, Diamond FB, Baxter RC, Rosenbloom AL, Rosenfeld RG. Gargosky SE, et al. J Clin Endocrinol Metab. 1993 Dec;77(6):1683-9. doi: 10.1210/jcem.77.6.7505289. J Clin Endocrinol Metab. 1993. PMID: 7505289
A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency.
Guevara-Aguirre J, Vasconez O, Martinez V, Martinez AL, Rosenbloom AL, Diamond FB Jr, Gargosky SE, Nonoshita L, Rosenfeld RG. Guevara-Aguirre J, et al. J Clin Endocrinol Metab. 1995 Apr;80(4):1393-8. doi: 10.1210/jcem.80.4.7536209. J Clin Endocrinol Metab. 1995. PMID: 7536209 Clinical Trial.
Body changes in adolescent patients with growth hormone receptor deficiency receiving recombinant human insulin-like growth factor I and luteinizing hormone-releasing hormone analogue: preliminary results.
Martinez V, Vasconez O, Martinez AL, Moreno Z, Davila N, Rosenbloom AL, Diamond FB, Bachrach L, Rosenfeld RG, Guevara-Aguirre J. Martinez V, et al. Acta Paediatr Suppl. 1994 Apr;399:133-6. doi: 10.1111/j.1651-2227.1994.tb13306.x. Acta Paediatr Suppl. 1994. PMID: 7949598 Clinical Trial.
97 results